InMed Pharmaceuticals Inc. INM 深 沪
等待开盘 07-10 09:30:00 美东时间
1.66
+0.010
+0.61%
华盛通- 最 高1.662
- 今 开1.6107
- 成交量 1.29万股
- 最 低 1.60
- 昨 收 1.65
- 总市值 550.13万
- 52周最高 2.75
- 市盈率 静 --
- 换手率 0.39%
- 52周最低 0.575
- 委 比 93.22%
- 总股本 331.41万
- 历史最高 3210.00
- 量 比 0.21
- 振 幅 3.76%
- 历史最低 0.575
- 每 手 1
- 风险率 0.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vivo Opportunity reports $371,785 purchase of InMed Pharma common shares
Vivo Opportunity reports $371,785 purchase of InMed Pharma common shares Vivo Opportunity, a 10% owner, boosted its stake in InMed Pharmaceuticals through open-market purchases. Vivo Opportunity Fund Holdings reported 718,444 common shares beneficially owned following the trades. Vivo Opportunity Ca
06-11 09:15
InMed Pharmaceuticals regains Nasdaq compliance on $1 minimum bid price rule
InMed Pharmaceuticals regains Nasdaq compliance on $1 minimum bid price rule InMed Pharmaceuticals regained compliance with Nasdaq’s $1 minimum bid price rule, removing a continued-listing risk for its shares. Nasdaq determined the stock closed at or above $1 for 10 consecutive business days from Ma
06-10 18:04
Penny Stock InMed Pharmaceuticals Merger Deal Targets Migraine Pipeline
InMed agrees to merge with Mentari Therapeutics to advance migraine drug candidates backed by $290 million in financing.
05-19 22:05
InMed and Mentari announce all-stock merger deal
Canadian pharmaceutical company InMed Pharmaceuticals (INM) added ~170% in the premarket on Tuesday after announcing an all-stock merger agreement with migraine drug developer Mentari Therapeutics to ...
05-19 20:51
InMed Pharmaceuticals To Merge With Mentari Therapeutics
Upon consummation of the transaction contemplated by the Agreement, the combined entity will operate as Mentari Therapeutics and trade on the Nasdaq Capital Market under a new ticker symbol. Mentari's parallel lead
05-19 20:07
InMed Highlights INM-901 Alzheimer’s Data in Q3 Update
InMed Pharmaceuticals ( ($INM) ) just unveiled an announcement. On May 6, 2026,...
05-07 18:52
InMed Pharmaceuticals GAAP EPS of -$0.73
InMed Pharmaceuticals press release (INM): Q3 GAAP EPS of -$0.73. As of March 31, 2026, the Company's cash, cash equivalents and short-term investments were $5.2 million, which compares to $10.8 milli...
05-07 06:08
Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Other gainers include ABTS, AKAN, VSME, OSRH, AREB, VIAV, PI, INM, and MRAM.
04-30 17:26
InMed Pharmaceuticals Reprices Investment Options to Attract Capital
An update from InMed Pharmaceuticals ( ($INM) ) is now available. On April 21 a...
04-28 06:56
InMed Pharmaceuticals Announces ATM Offering Prospectus Filing
InMed Pharmaceuticals ( ($INM) ) has issued an announcement. InMed Pharmaceutic...
04-04 05:00
